ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Emactuzumab Biosimilar - Anti-CSF-1-R Antibody - Low endotoxin, Azide free (A323415)

Recombinant humanized monoclonal antibody to CSF-1-R for ELISA, FACS, Functional Assay and In Vivo.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 12-18 business days.
Name
Emactuzumab Biosimilar - Anti-CSF-1-R Antibody - Low endotoxin, Azide free
Description
Recombinant humanized monoclonal antibody to CSF-1-R.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human, Mouse, Cynomolgus Macaque
Host
Humanized
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 145 kDa.
Purity
> 95% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
CD115, CSF-1 receptor, CSF-1R, EC:2.7.10.1, FMS, M-CSF-R, Macrophage colony-stimulating factor 1 receptor, Proto-oncogene c-Fms
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Emactuzumab Biosimilar - Anti-CSF-1-R Antibody - Low endotoxin, Azide free (A323415)? Please let us know so that we can list the citation on this page.

Alternative products to Emactuzumab Biosimilar - Anti-CSF-1-R Antibody - Low endotoxin, Azide free (A323415)

Proteins predicted to interact with CSF1R

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.2% Relevancy Score
98.7% Relevancy Score
98.3% Relevancy Score
97.4% Relevancy Score
96.4% Relevancy Score
96.2% Relevancy Score
95% Relevancy Score